Publications by authors named "I Haller"

Patients are at risk of experiencing medication errors during each transition of care (TOC), which can result in adverse drug events and readmissions. Implementing a pharmacist-led TOC service can optimize medication safety and patient outcomes by identifying and correcting medication discrepancies prior to hospital discharge. A pharmacist-led TOC service at a tertiary care center expanded services to review medications at discharge for all enrolled hospitalized patients, but data collection and review had yet to be performed.

View Article and Find Full Text PDF
Article Synopsis
  • The elimination of the X-waiver in January 2023 could boost the number of potential buprenorphine prescribers significantly (up to 13 times), but actual prescribing growth may not match this potential.
  • A study surveyed 305 nonwaivered primary care clinicians to identify factors that would influence their likelihood of prescribing buprenorphine if the X-waiver was removed, focusing on patient requests and access to a clinical decision-support (CDS) tool for opioid use disorder (OUD).
  • Results indicated that while only 26% of clinicians were influenced by patient requests to prescribe buprenorphine, 63% were more likely to do so with the help of the OUD-CDS, highlighting the need
View Article and Find Full Text PDF

Background: Most patients with heart failure (HF) have multimorbidity which may cause difficulties with self-management. Understanding the resources patients draw upon to effectively manage their health is fundamental to designing new practice models to improve outcomes in HF. We describe the rationale, conceptual framework, and implementation of a multi-center survey of HF patients, characterize differences between responders and non-responders, and summarize patient characteristics and responses to the survey constructs among responders.

View Article and Find Full Text PDF

Background: Multimorbidity and functional limitation are associated with poor outcomes in heart failure (HF). However, the individual and combined effect of these on health-related quality of life in patients with HF is not well understood.

Methods: Patients aged ≥30 years with two or more HF diagnostic codes and one or more HF-related prescription drugs from four U.

View Article and Find Full Text PDF

Objective: The Centers for Disease Control and Prevention's 2022 Clinical Practice Guideline for Prescribing Opioids for Pain cautioned that inflexible opioid prescription duration limits may harm patients. Information about the relationship between initial opioid prescription duration and a subsequent refill could inform prescribing policies and practices to optimize patient outcomes. We assessed the association between initial opioid duration and an opioid refill prescription.

View Article and Find Full Text PDF